Utah Medical Products, Inc.
UTMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $83 | $93 | $75 | $61 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $4 | $3 | $6 | $5 |
| Inventory | $9 | $10 | $9 | $7 |
| Other Curr. Assets | $0 | $0 | $1 | $0 |
| Total Curr. Assets | $96 | $106 | $90 | $73 |
| Property Plant & Equip (Net) | $10 | $11 | $10 | $11 |
| Goodwill | $14 | $14 | $13 | $14 |
| Intangibles | $3 | $5 | $10 | $18 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $26 | $29 | $34 | $42 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $123 | $135 | $124 | $116 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $4 | $4 | $3 |
| Total Curr. Liab. | $4 | $5 | $6 | $4 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1 | $1 | $2 | $3 |
| Other NC Liab. | $0 | $1 | $1 | $2 |
| Total NC Liab. | $1 | $2 | $4 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $5 | $7 | $10 | $8 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $129 | $138 | $126 | $115 |
| AOCI | -$12 | -$11 | -$12 | -$9 |
| Other Equity | $0 | $1 | $0 | $1 |
| Total Equity | $117 | $128 | $114 | $107 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $123 | $135 | $124 | $116 |
| Net Debt | -$83 | -$93 | -$75 | -$61 |